Exosomes From Induced Pluripotent Stem Cell-Derived Cardiomyocytes Promote Autophagy for Myocardial Repair

Area of Science:

• Regenerative Medicine
• Cardiovascular Biology
• Nanomedicine

Background:

• Induced pluripotent stem cells (iCMs) show promise for treating ischemic cardiomyopathy but face transplantation challenges.
• Exosomes secreted by iCMs (iCM-Ex) present a viable cell-free therapeutic alternative.
• iCM-Ex can be collected in vitro for potential patient-specific therapies.

Purpose of the Study:

• To investigate the therapeutic potential of iCM-Ex in treating myocardial infarction.
• To elucidate the cardioprotective mechanisms of iCM-Ex, particularly their role in regulating autophagy.
• To establish iCM-Ex as a cell-free therapeutic strategy for ischemic cardiomyopathy.

Main Methods:

• iCM-Ex were isolated and characterized using nanoparticle tracking analysis and electron microscopy.
• Therapeutic efficacy was assessed in vitro and in vivo models of myocardial infarction.
• Cardioprotective effects and molecular mechanisms were evaluated using assays for apoptosis, fibrosis, autophagy, and gene expression.

Main Results:

• iCM-Ex (≈140 nm) expressed characteristic exosomal markers (CD63, CD9) and shared microRNA profiles with parent iCMs.
• Treatment with iCM-Ex significantly improved cardiac function in mice post-myocardial infarction, reducing apoptosis and fibrosis.
• iCM-Ex treatment upregulated autophagosome production and autophagy flux in hypoxic cardiomyocytes both in vitro and in vivo.

Conclusions:

• iCM-Ex enhance post-myocardial infarction cardiac function by modulating autophagy in hypoxic cardiomyocytes.
• This study supports iCM-Ex as a potent cell-free therapeutic agent for ischemic cardiomyopathy.
• iCM-Ex represent a feasible patient-specific therapy, overcoming limitations of cell transplantation.